ALFA FinderBSE filing, BSE: 540204. Summary written from the filing by ALFA Finder's alert engine.
Eiko Lifesciences Ltd: key numbers
- Share price
- ₹50.69
- Market cap
- ₹69.55 Cr
- Revenue (annual)
- ₹52.57 Cr
- Net profit (annual)
- ₹4.50 Cr
- P/E (TTM)
- 13.5×Sector 28.2×
- Promoter holding
- 39.96%+0.05% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eiko Lifesciences Ltd
All →Eiko Lifesciences Merger & Restructuring
Eiko Lifesciences' wholly owned subsidiary Eiko Scientific Solutions LLP will form a 50:50 joint venture, Oval Eiko Resources, with Oval Projects Engineering. The JV targets compressed bio gas production and distribution.
Eiko Lifesciences Q2 FY27 Results: Net Profit ₹1.6 Cr, Up 23.1% YoY
Eiko Lifesciences Ltd reported revenue from operations of ₹17.7 Cr (+51.3% YoY) and net profit of ₹1.6 Cr (+23.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.6 Cr · +23.1% YoY
Eiko Lifesciences Board Meeting Date
Eiko Lifesciences has scheduled a board meeting for November 5, 2026, to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.
Eiko Lifesciences Convertible Warrants
Eiko Lifesciences allotted 1,50,000 equity shares upon conversion of warrants, receiving a balance payment of Rs. 0.62 Crore from promoter Lenus Finvest Private Limited.
- Value
- ₹0.62 Cr
- From
- Lenus Finvest Private Limited
Eiko Lifesciences Other Announcement
The company submitted the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Eiko Lifesciences Annual General Meeting
Eiko LifeSciences held its 49th Annual General Meeting on September 22, 2026. The meeting transacted business, including adoption of financial statements and appointment of directors.
Other board meeting outcome announcements
All →Jiwanram Sheoduttrai Industries Board Meeting Outcome
Jiwanram Sheoduttrai's board approved convening its 29th AGM on 30 November 2026 and re-appointing a retiring non-executive director. The board also approved the FY2025-26 Board's Report.
Finolex Cables Board Meeting Outcome
Finolex Cables' board approved amending its insider trading code of conduct on 7 November 2026. Amended code was filed under PIT Regulation 8(2).
Chatterbox Technologies Board Meeting Outcome
Chatterbox's board approved a Rs. 7 crore related-party ceiling with its UAE subsidiary and a vendor change for IPO funds. Monitoring agency and deviation reports were also noted.
BCC Fuba India Board Meeting Outcome
BCC Fuba India's board met on November 6, 2026 and took note of consolidated related party transactions for the half year ended September 30, 2026. No financial results, capital raise or other material decision was reported.
Voltas Board Meeting Outcome
Voltas Limited's board approved Deloitte Haskins & Sells as statutory auditors for five years from the 73rd AGM, replacing SRBC & Co. LLP, whose second and final term ends at that AGM. Subject to shareholder approval.
- Execution
- Five years: financial years 2027-28 to 2031-32 (from the 73rd AGM in 2027 to the 78th AGM in 2032)
CMX Holdings Board Meeting Outcome
Riwind Green Energy (formerly CMX Holdings) board approved altering its MOA main objects into six consolidated objects and a postal ballot notice. The change refocuses the company on solar, EPC, battery storage and renewable data-centre businesses.